Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Carol Webb currently holds 300,000 shares of Citius Pharmaceuticals, Inc. (CTXR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Carol Webb has been a net neutral trader of CTXR stock. They have purchased $0 and sold $0 worth of shares.
Carol Webb's most recent insider trade was on Sep 19, 2025, when they sold 300,000 shares at $0.00 per share.
Carol Webb serves as Executive at Citius Pharmaceuticals, Inc. (CTXR). They have executed 9 insider transactions totaling $0 over their tenure at the company.
Carol Webb holds the position of Executive at Citius Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
Carol Webb has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Carol Webb was on Mar 4, 2024, when they sold $241 worth of CTXR shares. This transaction involved 12,071 shares at $0.02 per share.
Carol Webb currently owns 300,000 shares of Citius Pharmaceuticals, Inc. (CTXR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Carol Webb's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Carol Webb has 9 Form 4 filings on record as an insider at Citius Pharmaceuticals, Inc..
Set alerts for Carol Webb and 40,000+ other insiders.